Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2009 by Pepscan Therapeutics.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
TFS Trial Form Support
Information provided by:
Pepscan Therapeutics
ClinicalTrials.gov Identifier:
NCT00895466
First received: May 6, 2009
Last updated: May 7, 2009
Last verified: May 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)